Watch for Suzetrigine Rxs for Pain
March 2025
The spotlight is on suzetrigine (Journavx), the first med in a new class of NON-opioid analgesics for acute pain in over 2 decades.
Suzetrigine is a “selective sodium channel blocker”...that prevents pain signals in the peripheral nervous system from reaching the brain.
It’s NOT a controlled substance...and it doesn’t have the warnings we see with opioids about misuse, dangerously slowed breathing, etc.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote